Answers are grounded in this paper and cite their sources.
Quality by design method improves precision and sustainability in HPLC drug analysis, suggesting better QC practices.
A Quality by Design (QbD) approach was employed to develop and optimize a novel and robust Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method for the simultaneous estimation of abiraterone acetate (ABTA) and prednisolone (PDS) in the pharmaceutical dosage form. The optimized method parameters were determined using a Central Composite Design (CCD) and included a run time of 8 minutes, the flow rate of 0.8 mL//min, and a column temperature of 25°C. The mobile phase comprised methanol and acetonitrile (90:10v/v) with detection at 260 nm. Retention times of 5.23 minutes for ABTA and 3.335 minutes for PDS were achieved, ensuring efficient separation with high resolution and minimal tailing. Method validation confirmed precision, accuracy, linearity, robustness, and system suitability in compliance with ICH guidelines, establishing the method’s reliability for routine use. Green analytical chemistry assessment using GAPI, AGREE, HPLC-EAT, and BAGI tools highlighted the method’s environmental sustainability, practicality, and safety. The development of this method supports efficient quality control by providing a precise, eco-friendly analytical solution for simultaneous drug analysis. Additionally, its adaptability for future pharmaceutical applications makes it a valuable tool for enhancing process efficiency and meeting sustainability goals.
No takes yet. Share an insight, caveat, or question.
Jagtap et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: